BURROWS SCOTT L (Chief Financial Officer) sold 13.3% of their position (15K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.31M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/27/2026ACC: 0001853327-26-000008
Officer· Chief Financial Officer
Since Mar 2026
-15K
Net shares
Net seller
$1.31M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
15K acquired · 30K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+15K
Price / share
$14.50
Trade value
$217.50K
% of position
15.3%
6/25/2026
97.99K→112.99K
Common Stock
Direct
Shares
−5K
Price / share
$87.12
Trade value
$435.60K
% of position
4.4%
6/25/2026
112.99K→107.99K
Common Stock
Direct
Shares
−10K
Price / share
$87.14
Trade value
$871.40K
% of position
9.3%
6/25/2026
107.99K→97.99K
Total
Net shares
+0.00
Net value
-$1.09M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/25/2026 | M · Option Exercise | +15K | $14.50 | $217.50K | 15.3% | 97.99K | 112.99K |
| Common Stock Direct | 6/25/2026 | S · Sale | −5K | $87.12 | $435.60K | 4.4% | 112.99K | 107.99K |
| Common Stock Direct | 6/25/2026 | S · Sale | −10K | $87.14 | $871.40K | 9.3% | 107.99K | 97.99K |
| Total | +0.00 | -$1.09M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
15K shares
Shares
−15K
Strike price
14.50
Held after
359.86K
Exercisable
—
6/25/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock15K shares | 6/25/2026 | M · Option Exercise | −15K | 14.50 | — | 359.86K |